-
-
Chen Qiyu: Stimulating Market Vitality with the System, Promoting Rapid Development of the Biopharmaceutical Industry with Innovation
2022-09-05
Hong Kong Exchanges and Clearing Limited’s (HKEX) Biotech Summit 2022 came to a successful conclusion on 1 September. The summit attracted more than 36,000 corporate representatives and investors from the healthcare industry to jointly explore the future of the global healthcare and biotechnology industries.Four panel discussions were held at the summit, and
-
-
Fosun International Demonstrates Resilience in its Interim Results and Receives “Buy” Ratings from Goldman Sachs, Morgan Stanley
2022-09-02
On 1 September 2022, after Fosun International Limited (HKEX stock code: 00656, “Fosun International”), together with its subsidiaries (“Fosun” or the “Group”) announced its 2022 interim results on 30 August, Goldman Sachs, Morgan Stanley, Daiwa Capital Markets and CICC issued research reports and unanimously assigned “Buy” or
-
-
Fosun’s Management Decodes 2022 Interim Results: Consolidate Globalization Capabilities to Create Greater Value
2022-09-02
(2 September 2022) Fosun International held its 2022 interim results presentation on 31 August in the form of online webcast. The management of Fosun International introduced Fosun’s corporate strategies, operational indicators, ESG performance and other topics of investors’ concern.“Globalization is not just about exporting Chinese products overseas, nor just importing
-
-
Fosun International 2022 Interim Results Highlights in a Glance
2022-09-02
Fosun International 2022 Interim Results Highlights in a Glance
-
-
Guo Guangchang, Chairman of Fosun International Meets Cai Run, Chinese Ambassador to Israel in Tel Aviv, Israel and Attends the Opening of AHAVA’s New Factory
2022-08-31
Recently, Guo Guangchang and his delegation went to Israel on a business trip. During his stay in Israel, Guo Guangchang met Cai Run, Chinese Ambassador to Israel, and conducted exchanges with Yoel Razvozov, Minister of Tourism of Israel and Shira Greenberg, Chief Economist of the Israeli Ministry of Finance. He also attended the opening of th
-
-
Fosun International Announces 2022 Interim Results: Total Revenue Amounted to RMB82.89 Billion, representing a year-on-year increase of 17.7% Technology and Innovation, and Globalization Continue to develop
2022-08-30
2022 Interim Results Summary and Highlights:Total revenue in the first half of 2022 amounted to RMB82.89 billion, representing a year-on-year increase of 17.7%; profit attributable to owners of the parent reached RMB2.70 billion, enterprise operation profit1 amounted to RMB2.33 billion, representing a year-on-year increase of 35.5%With profound industrial presence in more t
-
-
Guo Guangchang Meets Gu Hui, Consul-General of the People's Republic of China in Gothenburg, Sweden
2022-08-29
On 26 August 2022, Guo Guangchang, Chairman of Fosun International, met Gu Hui, Consul-General of the People's Republic of China in Gothenburg, Sweden, accompanied by the Economic and Commercial Office of the Consulate-General. Li Haifeng, Global Partner of Fosun, attended the meeting.Guo Guangchang reported Fosun's businesses in Sweden
-
-
Fosun International Listed in Forbes 2022 China ESG 50
2022-08-29
29 August 2022 - Forbes China recently released its “2022 China ESG 50” list. Fosun International has been included on the list for its outstanding ESG performance and its active contribution to the fight against the COVID-19 pandemic. Forbes China pointed out that ESG is still in its infancy in China, and the 50 selected companies are all pioneers in the field of ESG.Forbe
-
-
Fosun Pharma Announces 2022 Interim Results Stable Revenue Growth and Recurring Income, Elevating the Revenue Contribution of New Products, and Accelerating International Layout
2022-08-29
Highlights:Revenue forthe first half of 2022amounted toRMB21,340 million, an increase of 25.88% YOY;Net profit (after extraordinary gain or loss) attributable to shareholders of the listed company amounted toRMB1,862 million, an increase of 18.57% YOY; net cash flow from operating activitiesamounted toRMB1,820 million, an increase of 6.66% YOY;Revenue from co